#BREAKING: Zim To Switch To New ARV Drug With Less Side Effects

ZIMBABWE is ready to transition to Teno-Lamuvudine Dolutegrevir (TLD), an Anti-retro Viral (ARV) drug with less side effects, moving away from the Teno-Lamivudine-Efavirenz (TLE) a three in one drug that is taken once a day, a top health official has said By Michael Gwarisa The development comes barely a year after government through the Ministry of Health and Child Care (MoHCC) deferred rolling out of the Dolutegrevir drug following indications that it posed a great risk to women of child bearing age and adolescent girls which might lead to women…

Share
Read More

Structural & Ecological Approach Key To Advancing SRH Services Among Zim Youths

YOUTHS are a critical constituency in every given society and it is that period in life when one is young, and often refers to the phase between childhood and adulthood. The African Youth Charter defines youths or young people as every person between the ages of 15 and 35 years while the United Nations defines youth as persons between the ages of 15 and 24 and all UN statistics are based on this range. By Enock Musungwini Youths are a special group that requires carefully planned and specific programming to…

Share
Read More

Zim Has Enough Blood Stocks

THE country has enough blood stocks to sustain the national demand, contrary to media reports that the blood bank was facing acute blood shortages, National Blood Service of Zimbabwe (NBSZ) Public Affairs Manager, Ms Esther Massundah has said. By Michael Gwarisa In a statement, Ms Massundah said blood has a shelf life of 42 days and therefore it can only be normal for the blood bank to maintain a five day supply of blood every week and this does not mean there is a shortage. “Following a series of inquiries,…

Share
Read More